I JUST read on Twitter that Leni Robredo will keynote a University of Cambridge online forum. I suppose this means she will speak proper English and not her signature ersatz colegiala Taglish.
You know, I cannot fathom why this woman pushing 60 still insists on speaking in a girlish “pa-tweetums” effect manner.
The fact is, Leni Robredo is not even a colegiala and real colegialas don’t even speak that way. They speak proper English. Only Kris Aquino speaks that way.
It’s not just me but a lot of people find it irritating everytime Leni Robredo opens her mouth and starts speaking. Please, woman, you are supposed to be the vice president of the Philippines, enough of the pa-cute effect. It’s not working.
Maybe Leni Robredo should watch and listen to former President Gloria Arroyo when she speaks, she might learn a thing or two on how an adult leader and real colegiala speaks.
And speaking of adults, all the usual suspects, wokes and the “devotees to the cult of the yellow ribbon” could do was attack former senator Juan Ponce Enrile for his age. But what is wrong with being an old man, a senior citizen? They could not even come up with a proper rebuttal to all the facts he said. This shows the intelligence level, or the lack of it, of the so-called opposition.
The so-called opposition are running out of ideas and issues to throw at President Rodrigo Duterte and they’re also running out of time. It’s barely a year till the 2022 elections and they still have not come out with anyone as their standard bearer against the formidable Duterte effect.
Who do they have to show so far? Firstly, there’s Leni Robredo still playing coy, acting like a 16-year-old waiting for someone to ask her for a prom night date despite the fact that after all the photo-ops and all-out support of mainstream media, all she can manage is being consistent at almost the tail-end of all presidential surveys.
And then there’s retired Supreme Court Associate Justice Antonio Carpio who is as boring and irrelevant as Ely Pamatong, and equally ridiculous.
The latest and ongoing issue the so-called opposition are into now is throwing everything to discredit with the intention of derailing the vaccination program so they can once again blame the Duterte government, and these folks are banking on the perverted and damaged psyche of the Filipino plus their desire to be trendy with a generous helping of colonial mentality.
The strategy is vaccine preference (not science based but political and racist), knowing the Filipinos’ penchant for imported signature items preferably from the US or Europe which will result in vaccine hesitance, causing delay to meet vaccination targets, then blame Duterte. And that’s how evil they are.
And we segue to vaccine efficacy with excerpts from an article in www.gavi.org/vaccineswork:
Why even low-efficacy COVID-19 vaccine could still be extremely useful
Before the first Phase 3 trial results of any COVID-19 vaccines were published, the World Health Organization (WHO) had said any vaccines with a greater than 50% efficacy would be worth approving.
Then along came the Pfizer-BioNTech and Moderna vaccines with efficacies higher than 90%, and optimism about the prospect of vaccinating our way out of the pandemic soared.
Vaccines can be tweaked or modified, just as they are with flu each year, but with COVID-19 this may not be necessary if a large enough number of people are vaccinated and if the vaccines continue to provide a moderate level of protection against SARS-CoV-2. And even a low efficacy vaccine might suppress infections enough to ease immediate pressures on health systems and reduce deaths to an acceptable level, while more effective vaccines are developed and distributed.
In other words, even if a vaccine has a relatively low efficacy, its impact in preventing death and disease can still be significant.
A vaccine’s efficacy refers to how well it appears to protect people against a specific endpoint, such as severe disease, in clinical trials. However, its real-world effectiveness can often be a bit lower, because vaccine trials often exclude people whose immune response may be slightly weaker, such as those with underlying health conditions, older individuals or pregnant women.
The meaning of “vaccine efficacy” also depends on the clinical endpoint being measured. For instance, for preventing COVID-19 disease the efficacy of the Oxford-AstraZeneca vaccine is around 70%. But for preventing hospitalizations and deaths, it may be closer to 100%, since no COVID-19-related hospital admissions or deaths occurred in the vaccinated group.
An efficacy of 70% doesn’t mean that 30% of vaccinated people will get COVID-19. In the Oxford-AstraZeneca trial, 30 out of 5,807 participants who received the vaccine developed COVID-19 (0.5%), compared to 101 out of 5,829 of those who received the placebo (1.7%). So, there was a 70% reduction in the incidence of disease.
For prevention of symptomatic disease, the Pfizer-BioNTech vaccine has an efficacy of 95%. (brotherlouie16@gmail.com)/PN)
